Journal of Vaccine Research 2024, Vol.14, No.6, 287-296 http://medscipublisher.com/index.php/jvr 293 MMRV vaccine to children aged 9~10 months worked well and was safe. The children showed good immune responses to all the viruses included in the vaccine (Lalwani et al., 2015). This approach may be helpful in places where the disease risk is high, and healthcare services are limited. 7.2 Vaccine hesitancy and misinformation Vaccine hesitancy remains a big problem in some areas. People may fear vaccines because of wrong information, cultural beliefs, or a lack of trust in health systems. Some communities worry about vaccine safety, which lowers vaccination rates. False claims about the MMR vaccine, especially about its safety, have made some parents refuse to vaccinate their children. This has led to lower vaccine coverage in some places. To fix this problem, it is important to provide clear, correct information and improve education about vaccines. In some European countries, anti-vaccine groups have spread fear and false information. This has caused vaccination rates to drop and led to new outbreaks of measles and mumps (Povey et al., 2019; Prymula et al., 2021). These examples show why fighting misinformation and sharing facts about vaccine safety is so important. 7.3 Disruptions in vaccination during pandemics The COVID-19 pandemic has disrupted many vaccination programs around the world, including MMR. Lockdowns, the shift of healthcare resources to COVID-19, and people’s fear of going to clinics all reduced the number of routine vaccinations. These problems have made more people at risk for vaccine-preventable diseases. Studies warn that missed vaccinations could lead to new outbreaks of diseases like measles and mumps (Czajka et al., 2009; Deichmann et al., 2015). To solve this, health experts suggest doing catch-up vaccination campaigns. They also recommend giving COVID-19 shots together with other routine vaccines where possible. This can help rebuild vaccination rates and prevent new outbreaks. 8 Future Research Directions and Improvement Strategies 8.1 Development of next-generation combined vaccines New combined vaccines are being developed to improve protection against more diseases. These vaccines aim to offer strong and long-lasting immunity while keeping side effects low. The MMRV vaccine (measles, mumps, rubella, and varicella) has already shown good results over a 10-year period, with high effectiveness and safety (Povey et al., 2019; Prymula et al., 2021). Future research should focus on making these vaccines even better by adding more antigens without increasing side effects (White et al., 1997; Czajka et al., 2009). 8.2 Personalized vaccination strategies Different people may need different vaccination plans. This is especially true for people with weak immune systems or other health problems. Personalized vaccination could mean changing the timing of the shots or adjusting the dose to get the best protection with fewer risks. Some studies have shown that flexible vaccine schedules can still provide good immunity and safety (Lalwani et al., 2015; Santos et al., 2019). Future research should look at how to create the best vaccine plans for different groups, like people with chronic illnesses or weakened immune systems (Wang, 2024). 8.3 Enhanced viral surveillance and vaccine improvement It is important to keep watching for new virus strains. Some new strains may not respond as well to current vaccines. Good surveillance helps find these changes early so the vaccines can be updated in time. The MMRV vaccine has worked well against varicella, but keeping an eye on new virus types is still necessary (Povey et al., 2019; Prymula et al., 2021). Future work should use modern tools like genomic testing and real-time tracking to improve how we monitor viruses and update vaccines when needed.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==